Nianguo Dong
- Cardiology and Cardiovascular Medicine top 2%
- Molecular Biology top 10%
- Surgery top 5%
- Biomaterials top 2%
- Cancer Research top 5%
- Topics
- Cardiac Valve Diseases and Treatments (73 papers)Electrospun Nanofibers in Biomedical Applications (48 papers)Tissue Engineering and Regenerative Medicine (37 papers)
- Journals
- CirculationNature CommunicationsSHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesIraq
In The Last Decade
Nianguo Dong
167 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cardiology and Cardiovascular Medicine 1.2k
- Molecular Biology 1.1k
- Surgery 830
- Biomaterials 667
- Cancer Research 608
Countries citing papers authored by Nianguo Dong
This map shows the geographic impact of Nianguo Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianguo Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianguo Dong more than expected).
Fields of papers citing papers by Nianguo Dong
This network shows the impact of papers produced by Nianguo Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianguo Dong. The network helps show where Nianguo Dong may publish in the future.
Co-authorship network of co-authors of Nianguo Dong
This figure shows the co-authorship network connecting the top 25 collaborators of Nianguo Dong. A scholar is included among the top collaborators of Nianguo Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianguo Dong. Nianguo Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 12 | |
| 5 | 22 | |
| 6 | 4 | |
| 7 | 8 | |
| 8 | 5 | |
| 9 | Lumican promotes calcific aortic valve disease through H3 histone lactylationbreakdown → | 62 |
| 10 | 12 | |
| 11 | ALP Inhibitors Inhibit Inflammatory Responses and Osteoblast Differentiation in hVIC via AKT-ERK Pathways. | 2 |
| 12 | 47 | |
| 13 | 15 | |
| 14 | 49 | |
| 15 | 6 | |
| 16 | 36 | |
| 17 | 118 | |
| 18 | 40 | |
| 19 | 14 | |
| 20 | 2 |
About Nianguo Dong
Nianguo Dong is a scholar working on Cardiology and Cardiovascular Medicine, Biomaterials and Surgery, having authored 176 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (73 papers), Electrospun Nanofibers in Biomedical Applications (48 papers) and Tissue Engineering and Regenerative Medicine (37 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.2k citations), Biomaterials (667 citations) and Cancer Research (608 citations). Nianguo Dong has collaborated with scholars based in China, United States and Iraq. Frequent co-authors include Jiawei Shi, Tingwen Zhou, Fei Li, Weihua Qiao, Kang Xu, Yuming Huang, Shichao Guo, Jiawei Shi, Chunli Wang and Xingjian Hu. Their work appears in journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.